We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+0.59%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
AUM
$272M
AUM Growth
-$3.95M
Cap. Flow
-$3.5M
Cap. Flow %
-1.29%
Top 10 Hldgs %
39.34%
Holding
80
New
1
Increased
7
Reduced
49
Closed
1

Top Buys

Rank Stock Value
1
QEP
QEP RESOURCES, INC.
QEP
+$717K
2
BWA icon
BorgWarner
BWA
+$582K
3
SLB icon
SLB Ltd
SLB
+$356K
4
AEGN
Aegion Corp
AEGN
+$277K
5
KEYS icon
Keysight
KEYS
+$163K

Sector Composition

Rank Sector Weight
1 Healthcare 28.8%
2 Industrials 23.15%
3 Technology 15.86%
4 Energy 8.93%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIG icon
51
Transocean
RIG
$5.69B
$1.13M 0.42%
137,715
-11,706
-8% -$120K
CAT icon
52
Caterpillar
CAT
$401B
$1.09M 0.4%
10,123
-1,070
-10% -$109K
BIVV
53
DELISTED
Bioverativ Inc. Common Stock
BIVV
$1M 0.37%
16,702
-162
-1% -$9.22K
FLOW
54
DELISTED
SPX FLOW, Inc.
FLOW
$986K 0.36%
26,722
SPXC icon
55
SPX Corp
SPXC
$10.8B
$949K 0.35%
37,727
T icon
56
AT&T
T
$158B
$904K 0.33%
31,706
-2,760
-8% -$81.4K
VZ icon
57
Verizon
VZ
$193B
$823K 0.3%
18,437
-620
-3% -$28.9K
DVN icon
58
Devon Energy
DVN
$48.5B
$807K 0.3%
25,245
+360
+1% +$13.2K
SVU
59
DELISTED
SUPERVALU Inc.
SVU
$750K 0.28%
32,552
-263
-0.8% -$7K
AGN
60
DELISTED
Allergan plc
AGN
$716K 0.26%
2,946
MRK icon
61
Merck
MRK
$317B
$662K 0.24%
10,825
-534
-5% -$32.5K
CDK
62
DELISTED
CDK Global, Inc.
CDK
$632K 0.23%
10,180
-166
-2% -$10.4K
BWA icon
63
BorgWarner
BWA
$13.7B
$599K 0.22%
+16,057
New +$582K
JPM icon
64
JPMorgan Chase
JPM
$955B
$572K 0.21%
6,255
-1,765
-22% -$152K
TRV icon
65
Travelers Companies
TRV
$79.8B
$567K 0.21%
4,479
-1,050
-19% -$129K
BMY icon
66
Bristol-Myers Squibb
BMY
$130B
$535K 0.2%
9,600
MRSH
67
Marsh
MRSH
$91.4B
$510K 0.19%
6,543
JCI icon
68
Johnson Controls International
JCI
$93.1B
$496K 0.18%
11,432
VREX icon
69
Varex Imaging
VREX
$522M
$479K 0.18%
14,174
-400
-3% -$13.6K
ORCL icon
70
Oracle
ORCL
$416B
$396K 0.15%
7,900
RTX icon
71
RTX Corp
RTX
$300B
$391K 0.14%
5,085
COLM icon
72
Columbia Sportswear
COLM
$2.93B
$390K 0.14%
6,716
EW icon
73
Edwards Lifesciences
EW
$51.2B
$380K 0.14%
9,630
-2,400
-20% -$87.6K
WST icon
74
West Pharmaceutical
WST
$24.7B
$378K 0.14%
4,000
ED icon
75
Consolidated Edison
ED
$39.9B
$357K 0.13%
4,419
-970
-18% -$78.4K

Similar funds

Thompson Rubinstein Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Thompson Rubinstein Investment Management held 80 positions worth $272M, down 1.4% from $275M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 2.5%. Thompson Rubinstein Investment Management opened 1 new position and exited 1, leaving the 80-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q2 2017 buy was BorgWarner: 16,057 shares worth $599K.
  • Thompson Rubinstein Investment Management added most to QEP RESOURCES, INC. in Q2 2017, an estimated $717K increase.
  • Thompson Rubinstein Investment Management's biggest Q2 2017 reduction was Medtronic, cutting an estimated $464K.
  • Thompson Rubinstein Investment Management fully exited NVIDIA in Q2 2017, selling an estimated $327K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 39% of its $272M portfolio in Q2 2017.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 1 in Q2 2017.
  • Thompson Rubinstein Investment Management's portfolio value fell 1.4% quarter-over-quarter to $272M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q2 2017, filed 7 Jul 2017.